Robocath

📍 Rouen, France🗓 Founded 2009👥 72 employees💰 Last funded Nov 2024
Medical Equipment Manufacturing🌐 robocath.com
Website LinkedIn
Robocath is a french medtech which designs, develops and commercializes robotic solutions to treat cardiovascular diseases. R-One™ is the first european robotic-assisted solution for PCI. The company obtained the CE-mark for R-One™ in February 2019. It is designed to operate with precision and perform specific movements creating better interventional conditions (radioprotection). Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs. Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all. We are convinced that the future standard for minimally-invasive procedures is robot-based.
6
Total investors
0
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
5
Luxembourg
1
Investor activity2020–2024 · investors recorded per year
202032021220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Robocath?
Robocath has 6 investors on record on gritt.io.
When did Robocath last raise funding?
The most recent investment in Robocath recorded on gritt.io was in November 2024.
When was Robocath founded?
Robocath was founded in 2009.
What industry is Robocath in?
Robocath operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Robocath based?
Robocath is headquartered in Rouen, France.